IP Library Granted Patent US 10,632,309
Granted Patent B2
US 10,632,309 · App. 14/952,428 · Granted Apr 28, 2020

Systems and methods related to the treatment of back pain

Inventors: Meredith McGee (Cary, NC); Joseph W. Boggs, II (Carrboro, NC); John Chae (Strongsville, OH); Amorn Wongsarnpigoon (Chapel Hill, NC); Maria E. Bennett (Beachwood, OH)
Assignee: SPR THERAPEUTICS, INC.
A61N1/36071A61N1/0551A61N1/0558A61N1/36017A61N1/36021
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,632,309
App. No.
14/952,428
Granted
Apr 28, 2020
Kind
B2
Abstract

The present invention reduces pain and improves function long-term in persons with back pain using electrical stimulation in the back. This approach involves an electrical stimulation device including at least one electrode adapted for insertion within an animal body with back pain and at least one pulse generator operatively coupled with the at least one electrode, wherein the pulse generator delivers electrical stimulation activating at least a nerve innervating at least a paraspinal muscle in a back of the animal body for pain relief.

Claims (31)

1. A method to alleviate back pain, the method comprising the steps of:

placing a monopolar electrode within a tissue of an animal body, and applying electrical stimulation through the monopolar electrode through an external electrical stimulator to activate: (i) at least one efferent nerve fiber of the dorsal ramus of the animal body relieving pain and (ii) at least one paraspinal muscle without strengthening the paraspinal muscle.

2. The method of claim 1 , further comprising the step of modulating central neural processing through the activation of the at least one nerve near the dorsal ramus of the animal body.

3. The method of claim 2 , further comprising the step of producing an increase in stimulation-evoked neural encoded signals.

4. The method of claim 3 , further comprising the step of producing a change in efferent nerve fiber activity.

5. The method of claim 4 , further comprising the steps of evaluating an area of back pain.

6. The method of claim 5 , further comprising the step of repositioning the monopolar electrode at a location based on the area of back pain.

7. The method of claim 6 , further comprising the step of applying electrical stimulation through the monopolar electrode that has been repositioned.

8. The method of claim 7 , wherein the alleviation of back pain persists after the stimulation is discontinued.

9. The method of claim 8 , further comprising the steps of: inserting an additional electrode; applying electrical stimulation through the additional electrode; and comparing an area of muscle activation caused by the electrical stimulation with an area of pain.

10. The method of claim 9 , further comprising the steps of: removing the monopolar electrode; applying an electrical stimulation through the additional electrode; and re-comparing a second area of muscle activation caused by the electrical stimulation with the area of pain.

11. An electrical stimulation device comprising:

a monopolar electrode adapted for insertion within an animal body with back pain;

a percutaneous lead operatively coupled with the monopolar electrode; and

at least one pulse generator external to the animal body and operatively coupled with the electrode through the percutaneous lead, wherein the pulse generator delivers electrical stimulation activating at least one efferent nerve fiber of the dorsal ramus of the animal body for pain relief thereby resulting in activation of at least one paraspinal muscle without strengthening the paraspinal muscle.

12. The electrical stimulation device of claim 11 , wherein the percutaneous lead a coiled lead.

13. The electrical stimulation device of claim 12 , wherein the percutaneous lead includes an insulated portion and a deinsulated portion whereby the deinsulated portion forms the monopolar electrode.

14. The electrical stimulation device of claim 13 , wherein the percutaneous lead is implanted in the paraspinal muscle.

15. The electrical stimulation device of claim 13 , wherein the percutaneous lead includes a barb formed from the deinsulated portion.

16. The electrical stimulation device of claim 13 , wherein the percutaneous lead includes a taper between the insulated portion and deinsulated portion.

17. The electrical stimulation device of claim 1 , wherein the pulse generator delivers electrical stimulation activating the efferent nerve fiber in the back for a treatment period.

18. A method to alleviate back pain, the method comprising the steps of:

utilizing an electrical stimulation device in an animal body, the electrical stimulation device comprising:

at least one electrode adapted for insertion below skin of an animal body with back pain; and

an external pulse generator operatively coupled with the at least one electrode, wherein the external pulse generator delivers electrical stimulation for a prescribed period of time to activate an efferent nerve fiber of the dorsal ramus in a back of the animal body to cause muscle contraction to relieve pain without strengthening a paraspinal muscle activated by the efferent nerve fiber, said relief of pain lasting longer than the prescribed period of time.

19. The method of claim 18 , wherein the prescribed period of time is up to 24 hours per day for approximately one to twelve weeks.

20. The method of claim 19 , wherein the electrical stimulation device further comprises at least one lead.

21. The method of claim 20 , wherein the at least one lead is percutaneous.

22. The method of claim 20 , wherein the at least one lead is implanted in the tissue of the animal body.

23. The method of claim 22 , wherein the tissue is a paraspinal muscle.

24. The method of claim 22 , wherein the electrical stimulation device provides long-term use of greater than three weeks.

Assignments (9)
RELEASE OF SECURITY INTEREST Recorded Feb 8, 2024
From: THE DIRECTOR OF DEVELOPMENT, STATE OF OHIO, FORMERLY KNOWN AS THE DIRECTOR OF THE OHIO DEVELOPMENT SERVICES AGENCY
To: SPR THERAPEUTICS, INC., FORMERLY KNOWN AS SPR THERAPEUTICS, LLC
Reel/Frame 066526/0025 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Jan 30, 2024
From: SPR THERAPEUTICS, INC.
To: SLR INVESTMENT CORP., AS AGENT
Reel/Frame 066381/0075 →
SECURITY INTEREST Recorded Jan 30, 2024
From: SPR THERAPEUTICS, INC.
To: GEMINO HEALTHCARE FINANCE, LLC
Reel/Frame 066412/0400 →
RELEASE OF SECURITY INTEREST Recorded Oct 15, 2019
From: THE DIRECTOR OF THE OHIO DEVELOPMENT SERVICES AGENCY
To: SPR THERAPEUTICS, INC.
Reel/Frame 050728/0676 →
RELEASE OF SECURITY INTEREST Recorded Oct 15, 2019
From: THE DIRECTOR OF THE OHIO DEVELOPMENT SERVICES AGENCY
To: SPR THERAPEUTICS, INC.
Reel/Frame 050728/0721 →
CHANGE OF NAME Recorded Dec 6, 2017
From: SPR THERAPEUTICS, LLC
To: SPR THERAPEUTICS, INC.
Reel/Frame 044716/0812 →
SECURITY INTEREST Recorded Nov 9, 2017
From: SPR THERAPEUTICS, INC.
To: THE DIRECTOR OF THE OHIO DEVELOPMENT SERVICES AGENCY
Reel/Frame 044414/0575 →
SECURITY INTEREST Recorded Nov 9, 2017
From: SPR THERAPEUTICS, INC.
To: THE DIRECTOR OF THE OHIO DEVELOPMENT SERVICES AGENCY
Reel/Frame 044715/0395 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 9, 2017
From: MCGEE, MEREDITH; BOGGS, JOSEPH W.; CHAE, JOHN; WONGSARNPIGOON, AMORN; BENNETT, MARIA E.
To: SPR THERAPEUTICS, LLC
Reel/Frame 042295/0116 →
Cited By (1)
US 12,201,837